For: | Ma XL, Ge D, Hu XJ. Evaluation of teplizumab's efficacy and safety in treatment of type 1 diabetes mellitus: A systematic review and meta-analysis. World J Diabetes 2024; 15(7): 1615-1626 [PMID: 39099823 DOI: 10.4239/wjd.v15.i7.1615] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v15/i7/1615.htm |
Number | Citing Articles |
1 |
Brody Sundheim, Krish Hirani, Mateo Blaschke, Joana R. N. Lemos, Rahul Mittal. Pre-Type 1 Diabetes in Adolescents and Teens: Screening, Nutritional Interventions, Beta-Cell Preservation, and Psychosocial Impacts. Journal of Clinical Medicine 2025; 14(2): 383 doi: 10.3390/jcm14020383
|
2 |
Sunetra Mondal, Joseph M Pappachan. Current perspectives and the future of disease-modifying therapies in type 1 diabetes. World Journal of Diabetes 2025; 16(1): 99496 doi: 10.4239/wjd.v16.i1.99496
Abstract(211) |
Core Tip(203) |
Full Article(HTML)(1179)
|
Full Article with Cover (PDF)-12141K(47)
|
Audio-684K(4)
|
Peer-Review Report-234K(28)
|
Answering Reviewers-48K(27)
|
Supplementary Material-74K(29)
|
Full Article (PDF)-11580K(80)
|
Full Article (XML)-162K(27)
|
Times Cited (0)
|
Total Visits (2783)
|
Open
|
3 |
Qi Wu, Rui Wei, Xinyue Liao, Xiaona Cui, Haining Wang, Tianpei Hong. Anti-CD3 monoclonal antibody in treating patients with type 1 diabetes: an updated systematic review and meta-analysis. Cardiovascular Diabetology 2025; 24(1) doi: 10.1186/s12933-025-02696-7
|